Coronavirus disease 2019 (COVID-19) and immune-mediated rheumatic diseases. Recommendations of the association of rheumatologists of Russia
E. L. Nasonov,A. M. Lila,Vadim I. Mazurov,B. S. Belov,A. E. Karateev,Tatiana Dubinina,O. A. Nikitinskaya,A. A. Baranov,Diana Abdulganieva,S. V. Moiseev,A. I. Zagrebneva +10 more
- Vol. 59, Iss: 3, pp 239-254
Reads0
Chats0
TLDR
The new version of the recommendations of the Association of Rheumatologists of Russia formulates the main provisions concerning the tactics of managing patients with Immune-mediated Rheumatic Diseases during the ongoing COVID-19 pandemic.Citations
More filters
Journal ArticleDOI
Деплеция в-клеток при иммуновоспалительных ревматических заболеваниях и коронавирусная болезнь 2019 (covid-19)
Е. Л. Насонов,А. С. Авдеева +1 more
TL;DR: According to the recommendations of the Association of Rheumatologists of Russia, a more rigorous assessment of indications for induction and maintenance therapy of RTX therapy and harmonization of the timing of drug administration and vaccination is required.
Journal ArticleDOI
Vaccination against SARS-CoV-2 in rheumatic diseases: Safety issues
TL;DR: The frequency of exacerbation of RD after vaccination against COVID-19 seems to be quite low (5–7%) and has no significant associations with a specific vaccine or anti-rheumatic therapy, and unambiguous interpretation is difficult.
Journal ArticleDOI
Janus kinase inhibitors in immunoinflammatory diseases: 10 years of clinical practice in rheumatology
Evgeny Nasonov,T.V. Korotaeva +1 more
TL;DR: The current achievements, trends and recommendations regarding the use of JAK inhibitors in the treatment of IMIDs and also in the hyper-response phase of COVID-19 are reviewed.
Journal ArticleDOI
Rheumatoid arthritis and post-COVID-19 syndrome
TL;DR: It is thought that SARS-CoV-2 infection may be a trigger factor for new rheumatic musculoskeletal diseases, including rheumatoid arthritis or COVID-19 can unmask previously undetected RA, and arthritis in the post covid period may induce problems in differential diagnosis of rhematic diseases.
Journal ArticleDOI
Safety of COVID-19 vaccines in patients with immunoinflammatory rheumatic diseases (preliminary data)
TL;DR: Preliminary data suggest that vaccination against COVID-19 in patients with IRD appears to be quite safe, and further studies are needed to investigate the safety, immunogenicity, and clinical efficacy of CO VID-19 immunization in rheumatic patients.
References
More filters
Journal ArticleDOI
Patients with rheumatic diseases adhere to COVID-19 isolation measures more strictly than the general population
Femke Hooijberg,Laura Boekel,Erik H Vogelzang,Maureen Leeuw,Maarten Boers,Ronald van Vollenhoven,Willem F. Lems,Michael T. Nurmohamed,Gertjan Wolbink +8 more
Journal ArticleDOI
Risk and clinical outcomes of COVID-19 in patients with rheumatic diseases compared with the general population: a systematic review and meta-analysis.
TL;DR: In this paper, the authors performed a systematic review and meta analysis to assess the risk and clinical outcomes of COVID-19 in patients with rheumatic diseases compared with the general population.
Journal ArticleDOI
Coronavirus disease 2019, immune-mediated inflammatory diseases and immunosuppressive therapies - A Danish population-based cohort study.
Mohamed Attauabi,Jakob Benedict Seidelin,Oluf Krautwald Felding,Mads Damsgaard Wewer,Laura Kirstine Vinther Arp,Melek Zahra Sarikaya,Alexander Egeberg,Nora Vladimirova,Flemming Bendtsen,Johan Burisch +9 more
TL;DR: In this article, the authors investigated the association between COVID-19, frequent rheumatological, dermatological, gastrointestinal, and neurological IMIDs and immunosuppressants.
Journal ArticleDOI
High levels of immunosuppression are related to unfavourable outcomes in hospitalised patients with rheumatic diseases and COVID-19: first results of ReumaCoV Brasil registry.
Claudia Diniz Lopes Marques,Adriana Maria Kakehasi,Marcelo de Medeiros Pinheiro,Licia Maria Henrique Mota,Cleandro Pires de Albuquerque,Carolina Rocha Silva,Gabriela Porfirio Jardim Santos,Edgard Torres Reis-Neto,Pedro Matos,Guilherme Devide,Andréa Tavares Dantas,Rina Dalva Neubarth Giorgi,Adriana de Oliveira Marinho,Lilian David de Azevedo Valadares,Ana Karla Guedes de Melo,F.M. Ribeiro,Gilda Aparecida Ferreira,Flavia Patricia de Sena Santos,Sandra Lúcia Euzébio Ribeiro,Nicole Pamplona Bueno de Andrade,Michel Alexandre Yazbek,Viviane Angelina de Souza,Eduardo dos Santos Paiva,Valderílio Feijó Azevedo,Ana Beatriz Santos Bacchiega de Freitas,José Roberto Provenza,Ricardo Acayaba de Toledo,Sheilla Fontenelle,Sueli Carneiro,Ricardo Machado Xavier,Gecilmara Salviato Pileggi,Ana Paula Monteiro Gomides Reis +31 more
TL;DR: In this article, risk factors associated with unfavourable outcomes: emergency care, hospitalisation, admission to intensive care unit (ICU), mechanical ventilation and death in patients with immune-mediated rheumatic disease (IMRD) and COVID-19 were evaluated.
Journal ArticleDOI
Long-term hydroxychloroquine use in patients with rheumatic conditions and development of SARS-CoV-2 infection: a retrospective cohort study.
Chris A. Gentry,Mary Beth Humphrey,Mary Beth Humphrey,Sharanjeet Thind,Sharanjeet Thind,Sage C Hendrickson,George Kurdgelashvili,George Kurdgelashvili,Riley J. Williams +8 more
TL;DR: Hydxychloroquine was not associated with a preventive effect against SARS-CoV-2 infection in a large group of patients with rheumatological conditions.